Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. SS Innovations International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was -32.08%.
The historical rank and industry rank for SS Innovations International's ROC (Joel Greenblatt) % or its related term are showing as below:
SSII'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -33700 Med: -1827.64 Max: -12.91
Current: -12.91
During the past 10 years, SS Innovations International's highest ROC (Joel Greenblatt) % was -12.91%. The lowest was -33700.00%. And the median was -1827.64%.
SSII's ROC (Joel Greenblatt) % is ranked worse than 62.19% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 4.13
vs SSII: -12.91
SS Innovations International (NAS:SSII) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SS Innovations International ROC (Joel Greenblatt) % Chart
SSII vs LMRI, AVR, CBLL: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, SS Innovations International's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SS Innovations International ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SS Innovations International's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where SS Innovations International's ROC (Joel Greenblatt) % falls into.
SS Innovations International ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of -32.08% mean?
SS Innovations International (SSII) has a ROC (Joel Greenblatt) % of -32.08% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on SS Innovations International and its competitors. According to the industry distribution chart, SS Innovations International ranks #523 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 62.2%.
Is SS Innovations International's ROC (Joel Greenblatt) % too high?
SS Innovations International's current ROC (Joel Greenblatt) % is -32.08%. Based on the distribution chart, SS Innovations International ranks #523 out of 841 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SS Innovations International has a GF Score™ of 35/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SS Innovations International's ROC (Joel Greenblatt) % compare to LMRI and AVR?
According to the Medical Devices & Instruments industry distribution chart, SS Innovations International ranks #523 out of 841 companies for ROC (Joel Greenblatt) %. This places SS Innovations International in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 4.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.13, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on SS Innovations International and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SS Innovations International's current ROC (Joel Greenblatt) % is -32.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SS Innovations International stock overvalued right now?
Based on GuruFocus' analysis, SS Innovations International (SSII) is currently considered Possible Value Trap. The stock's GF Value™ is $18.53, compared to a current price of $3.36 — trading 81.9% below its estimated fair value. The current ROC (Joel Greenblatt) % is -32.08%. SS Innovations International's overall GF Score™ is 35/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For SS Innovations International (SSII), the current ROC (Joel Greenblatt) % is -32.08% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SS Innovations International (SSII) Overvalued in 2026?
Based on GuruFocus' analysis, SS Innovations International stock appears to be undervalued.
The current stock price of $3.36 is trading 81.9% below its estimated GF Value™ of $18.53.
GuruFocus considers SS Innovations International to be Possible Value Trap.
Key valuation signals for SSII:
ROC (Joel Greenblatt) %: -32.08%
GF Value™: $18.53 vs. price of $3.36 (81.9% below fair value)
No single metric tells the full story. See the SSII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.
35GF Score
Get the complete analysis for SSII
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSII has been successfully added to your 
